Drug Shortage Report for TARO-BUDESONIDE
Report ID | 173511 |
Drug Identification Number | 02494280 |
Brand name | TARO-BUDESONIDE |
Common or Proper name | BUDESONIDE |
Company Name | TARO PHARMACEUTICALS INC |
Market Status | MARKETED |
Active Ingredient(s) | BUDESONIDE |
Strength(s) | 0.5MG |
Dosage form(s) | SUSPENSION |
Route of administration | INHALATION |
Packaging size | 2 |
ATC code | R03BA |
ATC description | OTHER DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES, INHALANTS |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | |
Actual start date | 2022-04-14 |
Estimated end date | Unknown |
Actual end date | |
Shortage status | Actual shortage |
Updated date | 2024-05-07 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 130 EAST DRIVE BRAMPTON, ONTARIO CANADA L6T 1C1 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v36 | 2024-05-07 | French | Compare |
v35 | 2024-05-07 | English | Compare |
v34 | 2024-01-05 | French | Compare |
v33 | 2024-01-05 | English | Compare |
v32 | 2023-08-16 | French | Compare |
v31 | 2023-08-16 | English | Compare |
v30 | 2023-07-18 | French | Compare |
v29 | 2023-07-18 | English | Compare |
v28 | 2023-04-28 | French | Compare |
v27 | 2023-04-28 | English | Compare |
v26 | 2023-04-10 | French | Compare |
v25 | 2023-04-10 | English | Compare |
v24 | 2023-03-24 | French | Compare |
v23 | 2023-03-24 | English | Compare |
v22 | 2023-03-10 | French | Compare |
v21 | 2023-03-10 | English | Compare |
v20 | 2023-02-22 | French | Compare |
v19 | 2023-02-22 | English | Compare |
v18 | 2023-02-10 | French | Compare |
v17 | 2023-02-10 | English | Compare |